MedTrace Logo

Efficacy of Fluorescein Visualization of the Uterus in Detecting Endometrial Cancer Invasion

NCT01979003 · Status: COMPLETED · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2022-02-24

Study results available
· View outcomes & findings →

Summary

To determine if Fluorescein systemic injection during hysterectomy procedure can be useful in revealing the depth of endometrial cancer invasion.

Conditions

Interventions

DRUG

Fluorescein

Sponsors & Collaborators

  • University of Arkansas

    lead OTHER

Principal Investigators

  • Alexander Burnett, MD · University of Arkansas

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-09-30
Primary Completion
2019-10-02
Completion
2021-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01979003 on ClinicalTrials.gov